BHSC — Bioharvest Sciences Cashflow Statement
0.000.00%
Last trade - 00:00- CA$145.55m
- CA$152.79m
- $12.67m
- 55
- 23
- 45
- 36
Annual cashflow statement for Bioharvest Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 April 30th | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -5.13 | -6.58 | -9.83 | -11.2 | -12.6 |
| Depreciation | |||||
| Non-Cash Items | 3.9 | 2.79 | 2.78 | 1.3 | 3.22 |
| Accounting Change | |||||
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -0.45 | -0.364 | -0.134 | -0.02 | -0.017 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -1.69 | -3.88 | -6.79 | -9.24 | -8.52 |
| Capital Expenditures | — | -0.173 | -1.64 | -1.26 | -1.47 |
| Purchase of Fixed Assets | |||||
| Cash from Investing Activities | — | -0.173 | -1.64 | -1.26 | -1.47 |
| Financing Cash Flow Items | 2.23 | — | — | -0.038 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 2.23 | 4.93 | 10.8 | 8.14 | 13.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 0.532 | 0.872 | 2.33 | -2.38 | 3.62 |